Una aplicación móvil para el ictus ha demostrado que mejora la calidad de vida de los pacientes. Los resultados serán presentados en el congreso de la Sociedad Americana de Neurología en abril. La aplicación está dirigida a médicos pero mejora la comunicación con los pacientes y permite que estos últimos sigan mejor el tratamiento.
Current controversy surrounding health domains is rooted in the Internet’s growing importance as a health information source. In 2013, the International Telecommunication Union estimated that 38.8% (2.7 billion) of the world’s population used the Internet. Many of these users are seeking important health information online. In the United States, surveys report 72% of online adults accessed the Internet to find health information primarily on the subjects of diseases and treatments . Other regions, including the European Union and emerging markets, have also shown marked increases in online health information seeking and self-diagnosing behavior.
The importance of establishing an inclusive yet reliable presence for health information online is critical to future global health outcomes given the growing importance of the health Internet. However, .health and many other health-related gTLDs are now on sale to private sector entities that largely permit open and unrestricted use. Yet, the globalized nature of the Internet, the public health need for privacy, security, and quality health information, and the rapid expansion of online health technologies demonstrate a critical need to ensure proper governance of future health domains. Focusing on the public good can be a first and crucial step to ensure an accurate, reliable, and evidence-based online presence for health for this generation and the next.
MiradorSalud se complace en publicar el sexto video de una serie de micros conducidos por la Dra. Marianela Castés, experta en psiconeuroinmunología (PNI). En esta oportunidad, nos presenta un excelente micro, sumamente didáctico, en el cual analiza el comportamiento de la enfermedad. En otras palabras, la constelación de síntomas no específicos que acompañan a la [...]
El Dr. Albert Z. Kapikian murió el lunes 24 de febrero a la edad de 83 años. Fue médico, pionero en el campo de la virología y creador de la primera vacuna de rotavirus comercializada (RotaShield®). Fue el jefe de la Sección de Epidemiología del Laboratorio de Enfermedades Infecciosas (NIAID, por sus siglas en inglés) [...]
Cuando los ciudadanos de cualquier país o región del mundo padecen de un descontento sostenido y un deterioro de sus condiciones de vida, generado por algún problema mayor como una crisis financiera, conflictos sociales, políticos o religiosos, los afectados pueden llegar a los extremos de expresar su inconformidad de forma violenta como es el caso [...]
Key evidence suggests that as hospital systems in the US reach a crisis point – involving the transition to value-based purchasing and tying Medicare and Medicaid dollars to performance – quality of care must improve. In many ways hospital employees have become the most important piece of the puzzle to improve efficiency, lower costs and improve outcomes. Disengaged employees in the US who turnover, for example, are estimated to cost as much as $11 billion annually due to lost productivity and poor results. As hospital leadership faces a new domain of uncertainty and demands, and must use innovative technologies to better understand and improve engagement and performance of employees, two gamers think they have the answer: real-time evaluation, fun gaming interaction and a culture of positive reinforcement. The team at AMPT Health is gambling that their new SaaS solution will revolutionize performance evaluation.
Though the industry has made outstanding progress in adopting EMRs, the practice of data acquisition from patients remains cloudy.
A recommendation from the HITSC Meaningful Use Workgroup would require practices with electronic health records (EHRs) to allow 10 percent of patients to report PGHD electronically.
If approved in meaningful use stage 3, the final stage of HealthIT.gov’s EHR incentive program, it could push hospitals to incorporate patient-generated data.
This requirement may seem like a relatively simple intervention, but the ramifications are quite significant. If clinical decision-making is made on the basis of data supplied by patients and documented in the EMR, how can clinicians be sure that such data is complete, correct and valid? And will clinicians like me learn to rely on it, or will we disregard it due to concerns about its validity or barriers to integrating it into care flow?
Furthermore, if a patient is in control of her health data entry, who is ultimately responsible for its completeness and accuracy — the patient or the clinician?
Incorporating biometric data into the EMR, an exciting prospect, is even more complex. Though clinicians are quite familiar with data entry from FDA-approved medical devices such as blood glucose meters, pacemakers and pulmonary function units, data from a myriad of consumer-driven health devices (Fitbit and others) will soon seek to flex their way into EMRs.
Patients clearly value these data; a recent Pew Research report noted that 60 percent of adults claim to track their exercise routine, weight or diet, meaning providers have some catch-up to do in order to meet patients halfway. Some health systems, such as Partners HealthCare, have already been experimenting with the incorporation of PGHD from remote devices into the EMR, and other institutions should follow.
Consumer health data devices are moving ahead at a staggering pace, and while the health care system can’t quite keep up, strategic planning should be happening now.
Despite the challenges, incorporating PGHD is a necessary evolutionary step for health care. Intelligently designed, well-executed systems that fully incorporate and display PGHD in a meaningful way will improve shared decision-making and enable patients as active care partners. Keen clinicians and patients will stay closely tuned to the numerous transformations to come.
La bacteria SARM, o Staphylococcus aureus resistente a la meticilina, es una cepa resistente a varios tipos de antibióticos, por lo que la dificultad para tratar infecciones con esta bacteria son una preocupación médica